Login to Your Account

Faust Brings in €8M Bridge Financing, Aims For More

By James Etheridge

Wednesday, October 11, 2006

No Abstract


BioWorld International Correspondent

PARIS - Faust Pharmaceuticals, which is developing therapies for nervous system diseases, completed an €8.2 million insider bridge financing, which is intended to be the first tranche of a €25 million C round funding.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription